Antibody data
- Antibody Data
 - Antigen structure
 - References [4]
 - Comments [0]
 - Validations [0]
 
Submit
Validation data
Reference
Comment
Report error
- Product number
 - 21754-1-AP - Provider product page

 - Provider
 - Proteintech Group
 - Proper citation
 - Proteintech Cat#21754-1-AP, RRID:AB_10860265
 - Product name
 - PDE4C antibody
 - Antibody type
 - Polyclonal
 - Description
 - PDE4C antibody (Cat. #21754-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse, rat and has been validated for the following applications: WB,ELISA.
 - Reactivity
 - Human, Mouse, Rat
 - Host
 - Rabbit
 - Conjugate
 - Unconjugated
 - Isotype
 - IgG
 - Vial size
 - 20ul, 150ul
 
Submitted references		Inhibition of phosphodiesterase 4D suppresses mTORC1 signaling and pancreatic cancer growth.
				
Inhibition of prolyl hydroxylases increases hepatic insulin and decreases glucagon sensitivity by an HIF-2α-dependent mechanism.
				
Inhibition of PDE4/PDE4B improves renal function and ameliorates inflammation in cisplatin-induced acute kidney injury.
				
DC591017, a phosphodiesterase-4 (PDE4) inhibitor with robust anti-inflammation through regulating PKA-CREB signaling.
				
		
	
			Jeong MH, Urquhart G, Lewis C, Chi Z, Jewell JL
JCI insight 2023 Jul 10;8(13)
		JCI insight 2023 Jul 10;8(13)
Inhibition of prolyl hydroxylases increases hepatic insulin and decreases glucagon sensitivity by an HIF-2α-dependent mechanism.
			Riopel M, Moon JS, Bandyopadhyay GK, You S, Lam K, Liu X, Kisseleva T, Brenner D, Lee YS
Molecular metabolism 2020 Nov;41:101039
		Molecular metabolism 2020 Nov;41:101039
Inhibition of PDE4/PDE4B improves renal function and ameliorates inflammation in cisplatin-induced acute kidney injury.
			Xu M, Yu X, Meng X, Huang S, Zhang Y, Zhang A, Jia Z
American journal of physiology. Renal physiology 2020 Mar 1;318(3):F576-F588
		American journal of physiology. Renal physiology 2020 Mar 1;318(3):F576-F588
DC591017, a phosphodiesterase-4 (PDE4) inhibitor with robust anti-inflammation through regulating PKA-CREB signaling.
			Li H, Li J, Zhang X, Feng C, Fan C, Yang X, Zhang R, Zhu F, Zhou Y, Xu Y, Liu H, Tang W
Biochemical pharmacology 2020 Jul;177:113958
		Biochemical pharmacology 2020 Jul;177:113958
				No comments: Submit comment	
	
			
			No validations: Submit validation data